Alder Brooks is the only boutique executive search firm exclusively focused on recruiting Commercial leadership in Life Sciences & Healthcare.
We bring deep industry insight, a network of proven commercial professionals (Director to Board level), speed and flexibility. We share the market and candidate insights you request, and the candidate qualifications you require for oversized growth in key markets:
Life Sciences: Tools, Diagnostics, Devices & Therapeutics
The diagnostic tests, tools, devices, instruments, and therapeutics in Life Sciences are essential for conducting experiments, collecting data, analyzing biological processes, and treating patients—improving health, enhancing quality of life, and ultimately saving lives. The demand for transformational commercial leadership in these areas is more competitive than ever. Our core expertise is recruiting commercial leaders who can drive oversized growth and innovation in this rapidly evolving landscape.
Rising costs and reimbursement pressures are squeezing margins across healthcare. To stay ahead, companies need commercial leaders who can unlock new revenue streams and drive oversized growth. At Alder Brooks, we recruit executives who lead through complexity—and turn it into a competitive advantage. Whether you're building for early traction, scaling a growth platform, or expanding within a health system, we deliver leaders equipped to drive growth in healthcare’s most challenging environments.
Representative Search Areas:
Behavioral Health, Health Plans (Payers), Digital Health, Health Systems (Hospitals & IDNs), Healthcare Technology, Home Health, Infusion, Inpatient & Outpatient Clinics, Medical Device, Medical Technology, Pharmaceutical Services, Specialty Pharmacy
HealthTech
As payors increasingly deploy investment capital into technology-driven provider solutions, executive recruiting requires access to health tech leaders who can manage growth and also understand how to navigate the complexities of partner investments (both commercial and financial) in order to maximize strategic options and ultimately grow firm value.
Representative Search Areas:
Behavioral Health, Digital Health, EHR, Revenue Cycle Management (RCM), Telehealth
Early/Mid-Stage Cybersecurity
Due to today’s challenging funding landscape, early to mid-stage Cybersecurity businesses are under more pressure than ever to hire the very best go-to-market leadership in order to reach growth targets. Understanding and having access to the flow of potential candidates, their cultural fit, and their ability to thrive within a demanding and dynamically changing organization is critical.
Representative Search Areas:
Private Equity and Venture Capital Portfolio Companies
Representative Commercial Searches by Function
Board Leadership
Business Development
Corporate Development
General Management
Market Access (Managed Care)
Marketing
Medical Affairs
Sales
Strategy
Representative Commercial Searches by Title
Board Director
Chief Commercial Officer
Chief Executive Officer
Chief Marketing Officer
Chief Strategy Officer
Director-Sr. Director
General Manager
Head Of
Medical Science Liaison (MSL)
Product Manager
Sales Representative (Strategic)
VP-SVP-EVP
By understanding your strategic vision, goals and culture, we go to market as your ambassadors, building candidate pools that reflect your needs now and in the future. These are the commercial leaders that redefine your business and exceed growth expectations.
Meet the Team
Mike Mosunic
Co-Founder & CEO
Mike is the Co-Founder and CEO of Alder Brooks. He is a seasoned business leader and entrepreneur with a proven track record in commercial leadership, having co-founded Wolf Hill Group (sold to Slone Partners) and served as Chief Commercial Officer at Pathology, Inc. (sold to LabCorp).
Mike is the Co-Founder and CEO of Alder Brooks. He is a seasoned business leader and entrepreneur with a proven track record in commercial leadership, having co-founded Wolf Hill Group (sold to Slone Partners) and served as Chief Commercial Officer at Pathology, Inc.
Before co-founding Alder Brooks, Mike co-founded Wolf Hill Group, a cybersecurity executive search firm that was acquired by Slone Partners in 2022.
Earlier in his career, Mike was the second employee at Slone Partners, where he played a key role in the firm's growth, holding leadership positions including Chief Operating Officer and President of Cybersecurity. He also held VP of Sales roles at LabCorp and Sonic Healthcare and served as Chief Commercial Officer at Pathology, Inc., backed by ABS Capital (sold to LabCorp).
Mike graduated with honors from Le Moyne College, earned an M.A. in Applied Physiology from Columbia University, and completed his MBA at the Marshall School of Business, University of Southern California.
He enjoys skiing with his family, swimming, and walking his Bernese Mountain Dog in the Colorado mountains.
Read more
Read less
Stephen Skrenta
Advisory Board Member & Co-Founder
Stephen is an Advisory Board Member of Alder Brooks and Co-Founder. Stephen was formerly a Senior Managing Director within Blackstone’s advisory business located in New York and London.
Stephen is an Advisory Board Member of Alder Brooks and Co-Founder. Stephen was formerly a Senior Managing Director within Blackstone’s advisory business located in New York and London. While at Blackstone Stephen advised the firm's corporate and sovereign clients on acquisitions, divestitures, private capital raises, and financial restructurings. Stephen began his career on Wall Street at Donaldson, Lufkin & Jenrette. In 2015 Stephen founded Acabonac Farms, a regenerative agricultural enterprise that works to better the environment and improve animal and human health.
Stephen is a graduate of The University of Pennsylvania’s Wharton School.
Stephen is married, has three children, enjoys ranching, traveling and playing blackjack.
Read more
Read less
Vicki DiFrancesco
Board Advisor
Ms. Vicki DiFrancesco is an influential leader in the laboratory industry and was formerly responsible for building and executing XiFiN’s corporate business development strategies including acquisitions, joint ventures and strategic partnerships that advance company growth.
Ms. Vicki DiFrancesco is an influential leader in the laboratory industry and was formerly responsible for building and executing XiFiN’s corporate business development strategies including acquisitions, joint ventures and strategic partnerships that advance company growth. She remains a Strategic Advisor for XiFiN after retiring in 2022 and now is also a Board Advisor for Alder Brooks.
Ms DiFrancesco was appointed as the first member of US HealthTek’s Advisory Board in March 2023 and a Non Executive Board Director for SpeeDx in September 2023.
Prior to XIFIN, Vicki served as President and CEO of Pathology Inc., the west coast’s premier women’s health laboratory that was acquired by LabCorp in March 2016. Previously, DiFrancesco was Executive Vice President of Sales and Marketing for Spectrum Laboratory Network where she grew revenues and drove expansion into new markets. She also served as Senior Vice President, Sales and Marketing for Specialty Laboratories Inc., where she oversaw marketing, customer service and was instrumental in sale of company to Ameripath in 2005.
Earlier in her career, Vicki worked as the Vice President of Hospital Sales and Marketing at Quest Diagnostics, Inc.. She has also held executive level positions with American Medical Laboratories, sold to Quest Diagnostics, and Laboratory Corporation of America. Vicki formerly served on the Board of Directors of PWNHealth, LLC, sold to Spectrum Equity.
Read more
Read less
Christopher Mosunic, PhD, RD, MBA
Board Advisor
Chris is a licensed Clinical Psychologist and the Chief Clinical Officer at Calm, playing a key role in shaping the brand’s evidence-based programs and spearheading clinical research.
Chris is a licensed Clinical Psychologist and the Chief Clinical Officer at Calm, playing a key role in shaping the brand’s evidence-based programs and spearheading clinical research. With his wealth of experience as an executive healthcare leader at Yale New Haven Health, Johnson and Johnson, Rivermend Health, Advanced Recovery Systems, Vida Health, and a Board Advisor for Alder Brooks, Chris has demonstrated his expertise in building and leading integrated healthcare services.
Chris is also a seasoned Registered Dietitian, noted for his acumen in launching and growing health-focused organizations. His thought leadership is evident in the numerous scientific publications, clinical programs, and presentations he’s developed on a variety of topics such as cognitive behavioral therapy (CBT), mental health, integrated care, obesity, eating disorders, and substance use disorders.
Chris received his undergraduate degree in Biology & Psychology from Bucknell University, his MS in Nutritional Biochemistry from Tufts, his PhD in clinical psychology from Vanderbilt, and his MBA from Yale.
Read more
Read less
Advisory Board
Tim Johnson
Board Advisor
Infusion Diagnostics Life Sciences
Tim Johnson has over 25 years experience of combined healthcare private equity, M&A and financial advisory experience.
Tim Johnson has over 25 years experience of combined healthcare private equity, M&A and financial advisory experience. He has been an active investor and board member and led the growth in numerous healthcare companies including: Horizon Infusions, LabConnect Inc., BioInformatics Inc., Pathology Inc. (exited), DrugScan, Inc. and DSI Medical Services (exited), and DCL Medical Laboratories (exited).
Tim has been a Partner at BroadOak Capital, was a co-founder of Mt. Weather Capital, and founding partner of England & Company. Previously, he was an investment banker at Salomon Smith Barney, CIBC World Markets, and Friedman, Billings, Ramsey & Co. and began his career as a CPA at Arthur Andersen.
Tim earned a B.S. in Accounting (magna cum laude) and M.B.A. in Finance from the University of Maryland.
Read more
Read less
Vicki DiFrancesco
Board Advisor
Diagnostics HealthTech Life Sciences
Ms. Vicki DiFrancesco is an influential leader in the laboratory industry and was formerly responsible for building and executing XiFiN’s corporate business development strategies including acquisitions, joint ventures and strategic partnerships that advance company growth.
Ms. Vicki DiFrancesco is an influential leader in the laboratory industry and was formerly responsible for building and executing XiFiN’s corporate business development strategies including acquisitions, joint ventures and strategic partnerships that advance company growth. She remains a Strategic Advisor for XiFiN after retiring in 2022 and now is also a Board Advisor for Alder Brooks.
Ms DiFrancesco was appointed as the first member of US HealthTek’s Advisory Board in March 2023 and a Non Executive Board Director for SpeeDx in September 2023.
Prior to XIFIN, Vicki served as President and CEO of Pathology Inc., the west coast’s premier women’s health laboratory that was acquired by LabCorp in March 2016. Previously, DiFrancesco was Executive Vice President of Sales and Marketing for Spectrum Laboratory Network where she grew revenues and drove expansion into new markets. She also served as Senior Vice President, Sales and Marketing for Specialty Laboratories Inc., where she oversaw marketing, customer service and was instrumental in sale of company to Ameripath in 2005.
Earlier in her career, Vicki worked as the Vice President of Hospital Sales and Marketing at Quest Diagnostics, Inc.. She has also held executive level positions with American Medical Laboratories, sold to Quest Diagnostics, and Laboratory Corporation of America. Vicki formerly served on the Board of Directors of PWNHealth, LLC, sold to Spectrum Equity.
Read more
Read less
Christopher Mosunic, PhD, RD, MBA
Board Advisor
HealthTech
Chris is a licensed Clinical Psychologist and the Chief Clinical Officer at Calm, playing a key role in shaping the brand’s evidence-based programs and spearheading clinical research.
Chris is a licensed Clinical Psychologist and the Chief Clinical Officer at Calm, playing a key role in shaping the brand’s evidence-based programs and spearheading clinical research. With his wealth of experience as an executive healthcare leader at Yale New Haven Health, Johnson and Johnson, Rivermend Health, Advanced Recovery Systems, Vida Health, and a Board Advisor for Alder Brooks, Chris has demonstrated his expertise in building and leading integrated healthcare services.
Chris is also a seasoned Registered Dietitian, noted for his acumen in launching and growing health-focused organizations. His thought leadership is evident in the numerous scientific publications, clinical programs, and presentations he’s developed on a variety of topics such as cognitive behavioral therapy (CBT), mental health, integrated care, obesity, eating disorders, and substance use disorders.
Chris received his undergraduate degree in Biology & Psychology from Bucknell University, his MS in Nutritional Biochemistry from Tufts, his PhD in clinical psychology from Vanderbilt, and his MBA from Yale.
Read more
Read less
Insights for Life Sciences Leadership
Cutting-edge commercial perspectives on executive talent, leadership strategies, and industry trends in the life sciences sector.
Most companies hire Commercial leaders based on what they can see—résumés, titles, and interview polish. But real leadership fit runs deeper. This post breaks down why surface-level hiring (Phenotype) often fails—and how to assess the underlying traits, drivers, and behaviors (Genotype) that actually predict success. Includes a framework for reducing bias and expanding your access to diverse, high-performing talent.
Hiring a Chief Commercial Officer, VP of Sales, or VP of Marketing isn’t about instincts and interviews. It’s about structure. This post breaks down how to identify, benchmark, and hire Commercial leaders who actually drive growth in Life Sciences.
Investors and CEOs of Life Sciences companies aren’t looking for transactional recruiters — they want a partner who understands the pressure, the pace, and what’s at stake. This blog unpacks what they truly value and how Alder Brooks aligns with that mindset.
